Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration

Molecular Nutrition and Food Research

Volumn 56, Issue 3, 2012, Pages 466-474

  Legette, Leecole ^a,b   Ma, Lian ^b   Reed, Ralph L ^a,b   Miranda, Cristobal L ^a,b   Christensen, John Mark ^b   Rodriguez Proteau, Rosita ^b   Stevens, Jan F ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Bioavailability; Flavonoids; Hops; Pharmacokinetics; Xanthohumol

Indexed keywords

FLAVONOID; PROPIOPHENONE DERIVATIVE; XANTHOHUMOL;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; DOSE RESPONSE; DYSLIPIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MALE; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSLIPIDEMIAS; FLAVONOIDS; INJECTIONS, INTRAVENOUS; MALE; PROPIOPHENONES; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY;

HUMULUS; RATTUS;

EID: 84859175244     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100554     Document Type: Article

References (56)

1. Stevens, J. F., Ivancic, M., Hsu, V., Deinzer, M. L., Prenylflavonoids from Humulus lupulus. Phytochemistry 1997, 44, 1575-1585.
2. Stevens, J. F., Taylor, A. W., Deinzer, M. L., Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1999, 832, 97-107.
3. Miranda, C. L., Stevens, J. F., Ivanov, V., McCall, M. et al., Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem. 2000, 48, 3876-3884.
4. Lupinacci, E., Meijerink, J., Vincken, J. P., Gabriele, B. et al., Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha release in LPS-stimulated RAW 264.7 mouse macrophages and U937 human monocytes. J. Agric. Food Chem. 2009, 57, 7274-7281.
5. Peluso, M. R., Miranda, C. L., Hobbs, D. J., Proteau, R. R., Stevens, J. F., Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2). Planta Med. 2010, 76, 1536-1543.
6. Colgate, E. C., Miranda, C. L., Stevens, J. F., Bray, T. M., Ho, E., Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-κB activation in prostate epithelial cells. Cancer Lett. 2007, 246, 201-209.
7. Miranda, C. L., Stevens, J. F., Helmrich, A., Henderson, M. C. et al., Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol. 1999, 37, 271-285.
8. Miranda, C. L., Aponso, G. L., Stevens, J. F., Deinzer, M. L., Buhler, D. R., Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Cancer Lett. 2000, 149, 21-29.
9. Miranda, C. L., Yang, Y. H., Henderson, M. C., Stevens, J. F. et al., Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2. Drug Metab. Dispos. 2000, 28, 1297-1302.
10. Plazar, J., Filipic, M., Groothuis, G. M., Antigenotoxic effect of xanthohumol in rat liver slices. Toxicol. In Vitro 2008, 22, 318-327.
11. Gerhauser, C., Beer constituents as potential cancer chemopreventive agents. Eur. J. Cancer 2005, 41, 1941-1954.
12. Gerhauser, C., Alt, A., Heiss, E., Gamal-Eldeen, A. et al., Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 2002, 1, 959-969.
13. Dietz, B. M., Kang, Y. H., Liu, G., Eggler, A. L. et al., Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase. Chem. Res. Toxicol. 2005, 18, 1296-1305.
14. Xuan, N. T., Shumilina, E., Gulbins, E., Gu, S. et al., Triggering of dendritic cell apoptosis by xanthohumol. Mol. Nutr. Food Res. 2010, 54, S214-224.
15. Gerhauser, C., Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Mol. Nutr. Food Res. 2005, 49, 827-831.
16. Stevens, J. F., Page, J. E., Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry 2004, 65, 1317-1330.
17. Ferrari, C. K., Functional foods, herbs and nutraceuticals: Towards biochemical mechanisms of healthy aging. Biogerontology 2004, 5, 275-289.
18. Heber, D., Vegetables, fruits and phytoestrogens in the prevention of diseases. J. Postgrad. Med. 2004, 50, 145-149.
19. Kris-Etherton, P. M., Hecker, K. D., Bonanome, A., Coval, S. M. et al., Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113, 71S-88S.
20. Milner, J. A., Molecular targets for bioactive food components. J. Nutr. 2004, 134, 2492S-2498S.
21. Ford, E. S., Giles, W. H., Dietz, W. H., Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J. Am. Med. Assoc. 2002, 287, 356-359.
22. Nozawa, H., Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochem. Biophys. Res. Commun. 2005, 336, 754-761.
23. Mendes, V., Monteiro, R., Pestana, D., Teixeira, D. et al., Xanthohumol influences preadipocyte differentiation: implication of antiproliferative and apoptotic effects. J. Agric. Food Chem. 2008, 56, 11631-11637.
24. Rayalam, S., Yang, J. Y., Della-Fera, M. A., Park, H. J. et al., Anti-obesity effects of xanthohumol plus guggulsterone in 3T3-L1 adipocytes. J. Med. Food. 2009, 12, 846-853.
25. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Baile, C. A., Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis 2007, 12, 1953-1963.
26. Casaschi, A., Maiyoh, G. K., Rubio, B. K., Li, R. W. et al., The chalcone xanthohumol inhibits triacylglycerol and apolipoprotein B secretion in HepG2 cells. J. Nutr. 2004, 134, 1340-1346.
27. Dorn, C., Kraus, B., Motyl, M., Weiss, T. S. et al., Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Mol. Nutr. Food Res. 2010, 54, S205-S213.
28. Guo, J., Nikolic, D., Chadwick, L. R., Pauli, G. F., van Breemen, R. B., Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.). Drug Metab. Dispos. 2006, 34, 1152-1159.
29. Possemiers, S., Bolca, S., Grootaert, C., Heyerick, A. et al., The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J. Nutr. 2006, 136, 1862-1867.
30. Possemiers, S., Heyerick, A., Robbens, V., De Keukeleire, D., Verstraete, W., Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J. Agric. Food Chem. 2005, 53, 6281-6288.
31. Bolca, S., Possemiers, S., Maervoet, V., Huybrechts, I. et al., Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women. Br. J. Nutr. 2007, 98, 950-959.
32. Yilmazer, M., Stevens, J. F., Buhler, D. R., In vitro glucuronidation of xanthohumol, a flavonoid in hop and beer, by rat and human liver microsomes. FEBS Lett. 2001, 491, 252-256.
33. Yilmazer, M., Stevens, J. F., Deinzer, M. L., Buhler, D. R., In vitro biotransformation of xanthohumol, a flavonoid from hops (Humulus lupulus), by rat liver microsomes. Drug Metab. Dispos. 2001, 29, 223-231.
34. Jirasko, R., Holcapek, M., Vrublova, E., Ulrichova, J., Simanek, V., Identification of new phase II metabolites of xanthohumol in rat in vivo biotransformation of hop extracts using high-performance liquid chromatography electrospray ionization tandem mass spectrometry. J. Chromatogr. A. 2010, 1217, 4100-4108.
35. Nikolic, D., Li, Y., Chadwick, L. R., Grubjesic, S. et al., Metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus), by human liver microsomes. Drug Metab. Dispos. 2004, 32, 272-279.
36. Nookandeh, A., Frank, N., Steiner, F., Ellinger, R. et al., Xanthohumol metabolites in faeces of rats. Phytochemistry 2004, 65, 561-570.
37. Hanske, L., Loh, G., Sczesny, S., Blaut, M., Braune, A., Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol. Nutr. Food Res. 2010, 54, 1405-1413.
38. Reeves, P. G., Nielsen, F. H., Fahey, G. C., Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1951.
39. Food and Drug Administration, guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. 2005, Accessed on August 2, 2011.
40. Stevens, J. F., Taylor, A. W., Clawson, J. E., Deinzer, M. L., Fate of xanthohumol and related prenylflavonoids from hops to beer. J. Agric. Food Chem. 1999, 47, 2421-2428.
41. Ludden, T. M., Beal, S. L., Sheiner, L. B., Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection. J. Pharmacokinet. Biopharm. 1994, 22, 431-445.
42. Guidance for industry: Bioavailability and bioequivalence studies for orally administered drug products - general considerations. 2003, Accessed on August 2, 2011.
43. Chen, J., Lin, H., Hu, M., Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J. Pharmacol. Exp. Ther. 2003, 304, 1228-1235.
44. Jia, X., Chen, J., Lin, H., Hu, M., Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J. Pharmacol. Exp Ther. 2004, 310, 1103-1113.
45. Sfakianos, J., Coward, L., Kirk, M., Barnes, S., Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr. 1997, 127, 1260-1268.
46. Bovee, T. F., Helsdingen, R. J., Rietjens, I. M., Keijer, J., Hoogenboom, R. L., Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: A comparison of different compounds with both receptor types. J. Steroid Biochem. Mol. Biol. 2004, 91, 99-109.
47. Coldham, N. G., Sauer, M. J., Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem. Toxicol. 2001, 39, 1211-1224.
48. Kitaoka, M., Kadokawa, H., Sugano, M., Ichikawa, K. et al., Prenylflavonoids: a new class of non-steroidal phytoestrogen (Part 1). Isolation of 8-isopentenylnaringenin and an initial study on its structure-activity relationship. Planta Med. 1998, 64, 511-515.
49. Milligan, S., Kalita, J., Pocock, V., Heyerick, A. et al., Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 2002, 123, 235-242.
50. Milligan, S. R., Kalita, J. C., Heyerick, A., Rong, H. et al., Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 1999, 84, 2249-2252.
51. Milligan, S. R., Kalita, J. C., Pocock, V., Van De Kauter, V. et al., The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab. 2000, 85, 4912-4915.
52. Jeong, H. M., Han, E. H., Jin, Y. H., Choi, Y. H. et al., Xanthohumol from the hop plant stimulates osteoblast differentiation by RUNX2 activation. Biochem. Biophys. Res. Commun. 2011, 409, 82-89.
53. Stevens, J. F., Miranda, C. L., Frei, B., Buhler, D. R., Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the α, β-unsaturated keto functionality of 2'-hydroxychalcones as a novel antioxidant pharmacophore. Chem. Res. Toxicol. 2003, 16, 1277-1286.
54. Overk, C. R., Yao, P., Chadwick, L. R., Nikolic, D. et al., Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J. Agric. Food Chem. 2005, 53, 6246-6253.
55. Qiu, F., Chen, X. Y., Song, B., Zhong, D. F., Liu, C. X., Influence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in rats. Acta Pharmacol. Sin. 2005, 26, 1145-1152.
56. Setchell, K. D., Brown, N. M., Desai, P. B., Zimmer-Nechimias, L. et al., Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr. 2003, 133, 1027-1035.